Mechanism of Action and Clinical Implications of Concerta vs. Adderall

Core Pharmacological Differences

The American Academy of Child and Adolescent Psychiatry notes that Adderall has additional mechanisms, including monoamine oxidase inhibition and vesicular monoamine transporter 2 (VMAT-2) inhibition, making it pharmacologically more potent at comparable doses 1
Methylphenidate (Concerta) has agonist activity at serotonin type 1A receptors, redistributes VMAT-2, and primarily binds dopamine transporters in the striatum 1
Amphetamine (Adderall) inhibits dopamine and norepinephrine transporters, inhibits VMAT-2, and inhibits monoamine oxidase activity, further increasing monoamine levels 1

Both medications enhance dopamine and norepinephrine activity in the prefrontal cortex, improving executive function and attention, as noted by the American Academy of Child and Adolescent Psychiatry 1
They increase efficiency of prefrontal cortex activity and optimize executive and attentional function, enhancing inhibitory control and working memory 1
Both improve symptoms of inattention, hyperactivity, and impulsivity through their effects on frontal lobe function 1

The additional mechanisms of Adderall make it pharmacologically stronger at equivalent doses, as reported by the American Academy of Child and Adolescent Psychiatry 1
Concerta uses an osmotic release oral system (OROS) that produces an ascending-pattern plasma drug level throughout the day, equivalent to methylphenidate 5 mg three times daily when given as 18 mg Concerta, according to the Journal of the American Academy of Child and Adolescent Psychiatry 2
The OROS system is resistant to diversion, making it particularly suitable for adolescents, as noted by the Journal of the American Academy of Child and Adolescent Psychiatry 4

Both medications share similar side effects, including decreased appetite, sleep disturbances, and increased blood pressure and heart rate, as reported by the American Academy of Child and Adolescent Psychiatry 1
Methylphenidate plasma levels do not correlate with clinical response and provide no more predictive power than teacher and parent rating forms, according to the Journal of the American Academy of Child and Adolescent Psychiatry 2
Both medications carry risks of abuse, dependence, and cardiovascular effects at toxic doses, as noted by the Journal of the American Academy of Child and Adolescent Psychiatry 3